Harnessing the Power of Collagen
A Collagen-Based Technology for Regenerative Aesthetics and Tissue Reconstruction
Bridging advanced collagen-based technology with clinically validated tissue repair
Regenerative Aesthetics and Tissue Reconstruction
We are shaping the future of aesthetics and wound healing with our patented CXU™ platform. Conexeu bridges injectables, bio-stimulators, and tissue repair with our patented collagen IP platform. A collagen-based hydro-gel that is designed to promote tissue regeneration. The time is now for a global revolution in aesthetics and tissue engineering.
Unmet Global Need
Significant unmet global need for advanced scaffolds that promote tissue regeneration.
Groundbreaking Research
Groundbreaking translational and clinical research validates Conexeu’s potential for a regenerative scaffold across multiple tissue indications.
Pioneering Technology
Pioneering collagen-based scaffold platform enabling on-demand support for the formation of new functional tissues.
Industry Timing
The time has arrived for a next-generation biomaterial addressing needs in wound care and aesthetics.
Patented, Scalable Platform
Conexeu’s patented collagen-based scaffold technology is an investigational tissue regeneration platform currently being studied for applications ranging from soft-tissue enhancements to full tissue reconstruction, with the aim of advancing tissue regeneration.
Best-in-Class Collagen-Based Hydro-Gel
Grounded in wound healing research and supporting multiple advanced product pipelines.
Proprietary Platform
Developed over years of rigorous R&D and steered by a seasoned executive team driving breakthroughs in tissue regeneration.
Innovative Tissue Regeneration
Cutting-edge collagen-based technology enabling effective on-demand tissue repair and aesthetic solutions.
Ten Minute Tissue™
A temperature-activated collagen based scaffold transforming tissue repair.
Medical Aesthetics
Revolutionizing Aesthetics Through Tissue Regeneration
Igniting a paradigm shift in how aesthetics approaches tissue repair due to aging.
Reconstruction
Redefining Reconstructive Outcomes
From surface wounds to complex wounds, Conexeu’s ECM technology shortens recovery times and improves tissue integration – minimizing scarring while improving patient outcomes.
Conexeu Labs
Innovation at the Heart of Regeneration
Our R&D engine drives breakthroughs in biomimetic collagen-based scaffolds, fueling next-generation applications in tissue engineering, regeneration, and beyond.
Biostimulatory
An investigational approach designed to support native cells and tissue integration.
Regenerative
Our investigational collagen-based scaffold may support your body’s own tissue repair.
Biomimetic
Our technology is designed to mimic your body’s extracellular matrix.
Naturally Cross-Linked
Native human proteins, and sugars, gels in 10 minutes and is stable in the body.
Investors
A Transformational Opportunity in Regenerative Medicine
Growing Market Demand.
The global shift toward safer, natural aesthetic, and reconstructive solutions continues to expand.
Provisional Science.
Supported by preclinical peer-reviewed data, Conexeu’s patented collagen-based technology is being investigated for applications ranging from facial rejuvenation to large-volume body contouring.
Seasoned Leadership.
World-renowned physicians in aesthetics and wound care, tissue-engineering PhDs, former CEOs/CMOs of global aesthetics leaders, and medical device veterans with proven FDA-clearance track records.
“Join Us in Shaping the Future of Regenerative Medicine”
With its innovative collagen-based technology, Conexeu bridges the gap between facial fillers, biostimulators and tissue repair. We’re igniting a paradigm shift in how medicine approaches tissue repair. From investors seeking high-growth opportunities to clinicians pursuing safer and more effective therapies—everyone benefits from a future driven by true regeneration.
Join our newsletter to track our innovations and breakthroughs.
"*" indicates required fields